Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Smith

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Pharmacotherapy|November 17, 2023
Urinary biomarkers as indicators of acute kidney injury in critically ill children exposed to vancomycinAutumn M Spyhalsky, Se Jin Kim, Calvin J Meaney, et al.
Jac-Antimicrobial Resistance|January 9, 2026
Pharmacodynamic individualization of phage therapy against a KPC-5-producing <i>Pseudomonas aeruginosa</i>Thomas D Nguyen, Jacob T Sanborn, Brian M Ho, et al.
Frontiers in Microbiology|December 4, 2023
A mechanism-based pathway toward administering highly active N-phage cocktailsNicholas M Smith, Thomas D Nguyen, Wai Hoe Chin, et al.
International Journal of Antimicrobial Agents|June 30, 2024
PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguiseNicholas M Smith, Katie Rose Boissonneault, Patricia N Holden, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2024
Maximally precise combinations to overcome metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>Jan Naseer Kaur, Jack F Klem, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2026
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>Arunkumar Karunanidhi, Nidhi Singh, Jackson V Watkins, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2017
Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coliNicholas M Smith, Zackery P Bulman, Arthur O Sieron, et al.
Pharmacotherapy|October 7, 2021
Open-source maximum a posteriori-bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapyNicholas M Smith, Arthur Chan, Laura A Wilkinson, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection ModelJustin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
Scientific Reports|February 7, 2024
Next generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniaeJan Naseer Kaur, Navaldeep Singh, Nicholas M Smith, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Pharmacotherapy|November 17, 2023
Urinary biomarkers as indicators of acute kidney injury in critically ill children exposed to vancomycinAutumn M Spyhalsky, Se Jin Kim, Calvin J Meaney, et al.
Jac-Antimicrobial Resistance|January 9, 2026
Pharmacodynamic individualization of phage therapy against a KPC-5-producing <i>Pseudomonas aeruginosa</i>Thomas D Nguyen, Jacob T Sanborn, Brian M Ho, et al.
Frontiers in Microbiology|December 4, 2023
A mechanism-based pathway toward administering highly active N-phage cocktailsNicholas M Smith, Thomas D Nguyen, Wai Hoe Chin, et al.
International Journal of Antimicrobial Agents|June 30, 2024
PBP-3 directed therapy in VIM-producing Pseudomonas aeruginosa creates bacterial transformers, persisters in disguiseNicholas M Smith, Katie Rose Boissonneault, Patricia N Holden, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2024
Maximally precise combinations to overcome metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>Jan Naseer Kaur, Jack F Klem, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2026
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>Arunkumar Karunanidhi, Nidhi Singh, Jackson V Watkins, et al.
The Journal of Antimicrobial Chemotherapy|May 16, 2017
Pharmacodynamics of dose-escalated 'front-loading' polymyxin B regimens against polymyxin-resistant mcr-1-harbouring Escherichia coliNicholas M Smith, Zackery P Bulman, Arthur O Sieron, et al.
Pharmacotherapy|October 7, 2021
Open-source maximum a posteriori-bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapyNicholas M Smith, Arthur Chan, Laura A Wilkinson, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection ModelJustin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
Scientific Reports|February 7, 2024
Next generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniaeJan Naseer Kaur, Navaldeep Singh, Nicholas M Smith, et al.
Pageof 4